# Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts

**Authors:** Qing Chen, Ziyi Weng, Yunshu Lu, Yijun Jia, Longlong Ding, Fang Bai, Meixin Ge, Qing Lin, Kejin Wu

PMC · DOI: 10.1371/journal.pone.0311128 · PLOS ONE · 2024-09-23

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** Tumor (MESH:D009369), Breast Cancer (MESH:D001943)
- **Chemicals:** Fulvestrant (MESH:D000077267), Falsodex (-), Herceptin (MESH:D000068878)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11419337/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11419337/full.md

---
Source: https://tomesphere.com/paper/PMC11419337